Etoposide in the First-line Treatment of Adult EBV-HLH
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
his study aimed to investigate the efficacy of etoposide as the first line therapy for adult
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.